McLaughlin-Rotman Centre for Global Health, University Health Network and University of Toronto, Toronto, Canada and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada.
BMC Int Health Hum Rights. 2010 May 19;10:8. doi: 10.1186/1472-698X-10-8.
In recent years, the field of vaccines for diseases such as Human Immunodeficiency Virus (HIV) which take a heavy toll in developing countries has faced major failures. This has led to a call for more basic science research, and development as well as evaluation of new vaccine candidates. Human-animal chimeras, developed with a 'humanized' immune system could be useful to study infectious diseases, including many neglected diseases. These would also serve as an important tool for the efficient testing of new vaccine candidates to streamline promising candidates for further trials in humans. However, developing human-animal chimeras has proved to be controversial.
Development of human-animal chimeras for vaccine development has been slowed down because of opposition by some philosophers, ethicists and policy makers in the west-they question the moral status of such animals, and also express discomfort about transgression of species barriers. Such opposition often uses a contemporary western world view as a reference point. Human-animal chimeras are often being created for diseases which cause significantly higher morbidity and mortality in the developing world as compared to the developed world. We argue in our commentary that given this high disease burden, we should look at socio-cultural perspectives on human-animal chimera like beings in the developing world. On examination, it's clear that such beings have been part of mythology and cultural descriptions in many countries in the developing world.
To ensure that important research on diseases afflicting millions like malaria, HIV, Hepatitis-C and dengue continues to progress, we recommend supporting human-animal chimera research for vaccine development in developing countries (especially China and India which have growing technical expertise in the area). The negative perceptions in some parts of the west about human-animal chimeras can be used as an opportunity for nurturing important vaccine development research in the developing world.
近年来,在发展中国家造成严重损失的疾病疫苗领域,如人类免疫缺陷病毒(HIV)疫苗的研究遭遇了重大失败。这导致人们呼吁开展更多的基础科学研究、开发和评估新的候选疫苗。具有“人源化”免疫系统的人兽嵌合体可用于研究传染病,包括许多被忽视的疾病。这些也将成为高效测试新候选疫苗的重要工具,从而简化在人体中进一步试验有前途的候选疫苗的过程。然而,开发人兽嵌合体已被证明存在争议。
由于一些西方哲学家、伦理学家和政策制定者的反对,人兽嵌合体的开发用于疫苗的发展已经放缓——他们对这些动物的道德地位提出质疑,也对物种界限的跨越表示不适。这种反对往往以当代西方世界观为参照点。人兽嵌合体通常是为了在发展中国家比在发达国家发病率和死亡率更高的疾病而开发的。我们在评论中认为,鉴于这种高疾病负担,我们应该从发展中国家人兽嵌合体似的存在的社会文化角度来看待这个问题。经过审查,很明显,这些生物在发展中国家的许多国家的神话和文化描述中都有出现。
为确保继续推进困扰数百万人的疟疾、艾滋病毒、丙型肝炎和登革热等疾病的重要研究,我们建议支持发展中国家(特别是中国和印度,它们在该领域拥有日益增长的技术专长)的人兽嵌合体用于疫苗开发的研究。西方某些地区对人兽嵌合体的负面看法可以被用来作为在发展中国家培育重要疫苗开发研究的机会。